Erschienen in:
01.06.2014 | Correspondence
Tolerance and safety of intravenous streptomycin therapy in patients with tuberculosis
verfasst von:
R. Pérez Tanoira, F. Sánchez-Patán, A. Jiménez Girón, R. Fernández Roblas, J. Esteban, M. L. Fernández Guerrero
Erschienen in:
Infection
|
Ausgabe 3/2014
Einloggen, um Zugang zu erhalten
Excerpt
Although the clinical use of streptomycin has declined greatly, it is still a commonly used anti-tuberculous drug [
1]. Given the re-emergence of tuberculosis and the limited number of anti-tuberculous drugs, the use of streptomycin has gained renewed interest. …